Daniele Santini

Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case‐Control Study

Mario Cannataro, Giuseppe Agapito, Mariamena Arbitrio, 2019, Clinical pharmacology and therapeutics.

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma.

Laura La Paglia, Giuseppe Colucci, Vincenzo Adamo, 2010, Cancer treatment reviews.

A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid

Bruno Beomonte Zobel, Rosario Francesco Grasso, Giuseppe Tonini, 2007, Skeletal Radiology.

Targeting EGFR in bilio-pancreatic and liver carcinoma.

Stefania Tommasi, Giuseppe Colucci, Amalia Azzariti, 2011, Frontiers in bioscience.

Cancer chronotherapy: Principles, applications, and perspectives

Giuseppe Tonini, B. Vincenzi, G. Tonini, 2003, Cancer.

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

Sabine Tejpar, Federico Cappuzzo, Mauro Delorenzi, 2010, The Lancet. Oncology.

Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer

Carol Cass, Raymond Lai, Sergio Rizzo, 2010, Journal of cellular physiology.